Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87)

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 473-480

  Coleman, J L ^a   Gebbia, J A ^a   Benach, J L ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; LIPOTEICHOIC ACID; MEMBRANE PROTEIN; PROTEIN A; UROKINASE RECEPTOR;

ARTICLE; BACTERIAL INFECTION; BORRELIA BURGDORFERI; CELL MEMBRANE; CELL MIGRATION; CELL MOTION; CELL SURFACE; GENE OVEREXPRESSION; LYME DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SALMONELLA TYPHIMURIUM;

EID: 0035160526     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.473     Document Type: Article

References (44)

1. Lyme disease - A tick-borne spirochetosis?
2. Lyme disease
3. Lyme neuroborreliosis
4. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor
5. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers
6. Binding of human plasminogen to Borrelia burgdorferi
7. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete Borrelia burgdorferi
8. Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes
9. Plasmin-coated Borrelia burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix
10. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice
11. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis
12. Plasminogen activation by invasive human pathogens
13. Use of the plasminogen activation system by microorganisms
14. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages
15. A novel mechanism for the acquisition of virulence by a human influenza virus
16. r 55,000 form of the human plasminogen activator, urokinase
17. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
18. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator
19. Binding of singlechain prourokinase to the urokinase receptor of human U937 cells
20. r receptor protein for urokinase-type plasminogen activator: Identification in human tumor cell lines and partial purification
21. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells
22. Cellular receptor for urokinase plasminogen activator: Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
23. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells
24. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs
25. The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation
26. Cancer invasion and tissue remodeling cooperation of protease systems and cell types
27. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e
28. Urokinase receptor in human malignant mesothelioma cells: Role in tumor cell mitogenesis and proteolysis
29. Endotoxin stimulates expression of the murine urokinase receptor gene in vivo
30. Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia
31. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB
32. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins
33. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages
34. Lyme borreliosis in selected strains and ages of laboratory mice
35. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro
36. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis
37. Glycolytic enzyme operon of Borrelia burgdorferi: Characterization and evolutionary implications
38. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer
39. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: Increased concentrations in rheumatoid arthritis
40. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression
41. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors
42. Cellsurface acceleration of urokinase-catalyzed receptor cleavage
43. Genomic sequence of a Lyme disease spirochaete Borrelia burgdorferi
44. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro